Loading…

Protocol - Perception of Tobacco Product Harm - Cigarettes

Add to My Toolkit
Description

This protocol includes questions from Wave 3 of the Adult Population Assessment of Tobacco and Health Study survey instrument. These specific questions are used to measure a respondent’s perception about the perceived harm of smoking cigarettes. The three response categories range from less harmful to more harmful.

Specific Instructions

The Smoking Cessation, Harm Reduction, and Biomarkers Working Group recommends categorizing respondents based on the following reported use characteristics, according to the Use of Tobacco Products protocol: (1) ever user versus never user; (2) current established user, defined as everyday user or some-day user; and (3) former established user. Polyuse with other tobacco products should be considered as well.

Current and former users might also be categorized based on type of cigarette smoked: menthol flavor or nonmenthol flavor.

The Smoking Cessation, Harm Reduction, and Biomarkers Working Group also suggests questions 2 and 3 be considered to get at brand descriptors that might modify cigarette harm perceptions.

Availability

Available

Protocol

1. Do you think the brand of cigarettes you [usually smoke | usually smoked | last smoked] might be less harmful, no different, or more harmful, compared to other cigarette brands?

[ ] 1 Less harmful

[ ] 2 No different

[ ] 3 More harmful

[ ] -8 DONT KNOW

[ ] -7 REFUSED

2. Do you think a tobacco product described as additive-free is less harmful, about the same, or more harmful than a regular tobacco product?

[ ] 1 Less harmful

[ ] 2 About the same

[ ] 3 More harmful

[ ] -8 DONT KNOW

[ ] -7 REFUSED

ASK: All adult respondents.

3. Do you think a tobacco product described as organic is less harmful, about the same, or more harmful than a regular tobacco product?

[ ] 1 Less harmful

[ ] 2 About the same

[ ] 3 More harmful

[ ] -8 DONT KNOW

[ ] -7 REFUSED

ASK: All adult respondents.

Personnel and Training Required

None

Equipment Needs

The PhenX Working Group acknowledges that these questions can be administered in a computerized or noncomputerized format (i.e., paper-and-pencil instrument). Computer software is necessary to develop computer-assisted instruments. The interviewer will require a laptop computer/handheld computer to administer a computer-assisted questionnaire.

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training No
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual No
Mode of Administration

Interviewer-administered questionnaire

Lifestage

Adolescent, Adult

Participants

Adult (aged 18 or older)

Adolescent (aged 12-17)

Selection Rationale

The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, in-person longitudinal cohort study of nonusers and users of tobacco products and those at risk for tobacco use across the United States. Respondents aged 12 years or older are asked questions on tobacco use, attitudes, and health, and biospecimens (buccal cell, urine, and blood) are collected from adults. The PATH Study was implemented to provide an evidence base for assessing and monitoring the U.S. Food and Drug Administrations regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns.

Language

English, Spanish

Standards
StandardNameIDSource
Human Phenotype Ontology Addictive behavior HP:0030858 HPO
Derived Variables

None

Process and Review

Not Applicable

Protocol Name from Source

Population Assessment of Tobacco and Health (PATH) Study, PATH Wave 3 Adult Annotated Instrument, 2018

Source

U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse; and U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products, Population Assessment of Tobacco and Health (PATH) Study, 2018, Wave 3 Adult Annotated Instrument, items AC9019, AX0723, AX0724. Distributed October 21, 2020, by Inter-university Consortium for Political and Social Research, Ann Arbor, MI.

General References

Elton-Marshall, T., Driezen, P., Fong, G. T., Cummings, K. M., Persoskie, A., Wackowski, O., Choi, K., Kaufman, A., Strong, D., Gravely, S., Taylor, K., Kwan, J., Bansal-Travers, M., Travers, M., & Hyland, A. (2020). Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Addictive Behaviors, 106, 106337.

Fong, G. T., Elton-Marshall, T., Driezen, P., Kaufman, A. R., Cummings, K. M., Choi, K., Kwan, J., Koblitz, A., Hyland, A., Bansal-Travers, M., Carusi, C., & Thompson, M. E. (2019). U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013-14 baseline wave 1 of the PATH Study. Addictive Behaviors, 91, 180-187.

Leas, E. C., Ayers, J. W., Strong, D. R., & Pierce, J. P. (2017). Which cigarettes do Americans think are safer? A population-based analysis with wave 1 of the PATH Study. Tobacco Control, 26(e1), e59-e60.

Pearson, J. L., Johnson, A., Villanti, A., Glasser, A. M., Collins, L., Cohn, A., Rose, S. W., Niaura, R., & Stanton, C. A. (2017). Misperceptions of harm among Natural American Spirit smokers: Results from wave 1 of the Population Assessment of Tobacco and Health (PATH) Study (2013-2014). Tobacco Control, 26(e1), e61-e67.

Protocol ID

330501

Variables
Export Variables
Variable Name Variable IDVariable DescriptiondbGaP Mapping
PX330501_Perception_Risk_Cigarettes_Additive_Free_Harmful
PX330501020000 Do you think a tobacco product described as more
additive-free is less harmful, about the same, or more harmful than a regular tobacco product? show less
N/A
PX330501_Perception_Risk_Cigarettes_Brand_Harmful
PX330501010000 Do you think the brand of cigarettes you more
[usually smoke I usually smoked | last smoked] might be less harmful, no different, or more harmful, compared to other cigarette brands? show less
N/A
PX330501_Perception_Risk_Cigarettes_Organic_Harmful
PX330501030000 Do you think a tobacco product described as more
organic is less harmful, about the same, or more harmful than a regular tobacco product? show less
N/A
Smoking Cessation, Harm Reduction and Biomarkers
Measure Name

Perception of Tobacco Product Harm

Release Date

February 23, 2021

Definition

Instrument used to assess respondents' perception of how much they think people risk harming themselves by using tobacco products and of the relative harm between low-risk products and combustible cigarettes.

Purpose

The purpose of this measure is to collect information from respondents on their thoughts about the physical and health harms associated with using tobacco products. Perceptions of harm of tobacco products are important in predicting first use and continued use.

Keywords

Perceived harm, product harm, Population Assessment of Tobacco and Health, PATH, National Institutes of Health, NIH, U.S. Food and Drug Administration, FDA, Smoking Cessation, Harm Reduction, and Biomarkers, cigarettes, tobacco

Measure Protocols
Protocol ID Protocol Name
330501 Perception of Tobacco Product Harm - Cigarettes
330502 Perception of Tobacco Product Harm - E-Cigarettes
330503 Perception of Tobacco Product Harm - Cigars
330504 Perception of Tobacco Product Harm - Pipe Tobacco
330505 Perception of Tobacco Product Harm - Smokeless Tobacco
Publications

There are no publications listed for this protocol.